Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7394936> ?p ?o }
Showing triples 1 to 28 of
28
with 100 triples per page.
- Q7394936 subject Q7478371.
- Q7394936 subject Q8802906.
- Q7394936 subject Q8824860.
- Q7394936 abstract "SU6656 is a Src family kinase inhibitor developed by the biotechnology company SUGEN Inc (a subsidiary of Pharmacia) in 2000. SU6656 was initially identified as a Src kinase inhibitor by virtue of its ability to reverse an effect that an activated mutant form of Src (hu SRC Y530F) has on the actin cytoskeleton, namely the formation of podosome rosettes, otherwise known as invadopodia. SU6656 was initially published as a Src family kinase inhibitor with selectivity relative to Platelet-derived growth factor receptor Tyrosine kinase. Subsequent studies have confirmed that SU6656 is relatively selective for Src family kinases but some additional biochemical activities have been identified including: BRSK2, AMPK, Aurora C, Aurora B, CaMKKβ. The inhibition of these kinases in biochemical reactions in vitro does not necessarily indicate that these kinases are targets of SU6656 in cells.SU6656 has been used primarily as a research tool to investigate the function of Src family kinases in cellular signal transduction processes and biology.".
- Q7394936 iupacName "(3Z)-N,N-Dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-2,3-dihydro-1H-indole-5-sulfonamide".
- Q7394936 thumbnail SU6656.svg?width=300.
- Q7394936 wikiPageWikiLink Q10676833.
- Q7394936 wikiPageWikiLink Q154626.
- Q7394936 wikiPageWikiLink Q185269.
- Q7394936 wikiPageWikiLink Q309510.
- Q7394936 wikiPageWikiLink Q3498029.
- Q7394936 wikiPageWikiLink Q7202242.
- Q7394936 wikiPageWikiLink Q7207063.
- Q7394936 wikiPageWikiLink Q7251487.
- Q7394936 wikiPageWikiLink Q7394963.
- Q7394936 wikiPageWikiLink Q7478371.
- Q7394936 wikiPageWikiLink Q8802906.
- Q7394936 wikiPageWikiLink Q8824860.
- Q7394936 wikiPageWikiLink Q898992.
- Q7394936 iupacname "-N,N-Dimethyl-2-oxo-3--2,3-dihydro-1H-indole-5-sulfonamide".
- Q7394936 type ChemicalCompound.
- Q7394936 type ChemicalSubstance.
- Q7394936 type ChemicalObject.
- Q7394936 type Thing.
- Q7394936 type Q11173.
- Q7394936 comment "SU6656 is a Src family kinase inhibitor developed by the biotechnology company SUGEN Inc (a subsidiary of Pharmacia) in 2000. SU6656 was initially identified as a Src kinase inhibitor by virtue of its ability to reverse an effect that an activated mutant form of Src (hu SRC Y530F) has on the actin cytoskeleton, namely the formation of podosome rosettes, otherwise known as invadopodia.".
- Q7394936 label "SU6656".
- Q7394936 depiction SU6656.svg.